Latest News and Press Releases

Reported positive results from aleniglipron Phase 2 ACCESS II study with up to 16.3% body weight loss, demonstrating highest efficacy among oral GLP-1RAs at the 44-week time point and potentially...

Achieves all first quarter guidance metrics Delivers sixth consecutive quarter of GAAP profitability Strengthens balance sheet and liquidity position Reiterates full-year 2026 guidance   SAN MATEO,...

FRAMINGHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare” or the “Company”) (Nasdaq: DH), an industry leader in healthcare market data and analytics,...

MALVERN, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...

Nutanix announced that it will report its financial results for the third quarter of fiscal year 2026 after U.S. markets close on Wednesday, May 27, 2026.

CONSHOHOCKEN, Pa., May 07, 2026 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic...

First Quarter 2026 Highlights Revenue of $70.6 million versus $65.8 million in the prior year periodNet loss of $3.5 million versus net loss of $5.3 million in the prior year periodAdjusted net...

VISTA, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX) (“Flux Power” or the “Company”), a leading developer of advanced lithium-ion energy storage solutions and...

Topline data from 400-person sentinel cohort of the Phase 2b COVID-19 trial anticipated in Q2 2026 Cash, cash equivalents, and investments of $61.0 million as of March 31, 2026; runway into second...

Delivered Total and Net Investment Income of $29.5 million and $10.6 million, Respectively Investment Portfolio of $886.3 million Conference Call Today, Thursday, May 7, 2026 at 5:00 p.m. ET MENLO...